Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985;20(3):209-13.
doi: 10.1007/BF00205578.

Effect of melphalan in vitro on induction of murine suppressor T cells by ConA

R Ophir, S Ben-Efraim

Effect of melphalan in vitro on induction of murine suppressor T cells by ConA

R Ophir et al. Cancer Immunol Immunother. 1985.

Abstract

The effect of treatment with melphalan in vitro on the activity of spleen cells from BALB/c mice was investigated. Incubation of spleen cells with 1.5-5 micrograms melphalan/1 X 10(7) inhibited subsequent mitogenic stimulation by ConA or PHA and the allogeneic response of BALB/c spleen cells against C57B1 target spleen cells. Incubation of spleen cells with ConA led to induction of suppressor T cells which when added to fresh cultures inhibited the allogeneic response. Preincubation of spleen cells with melphalan even at low concentrations (0.15-0.5 micrograms 1 X 10(7) cells) which do not directly affect mitogenic stimulation or allogeneic response partially inhibited the generation of suppressor T cells by ConA. Treatment with melphalan had no effect on already induced suppressor T cells as shown by incubation of spleen cells with melphalan (0.15-5 micrograms/1 X 10(7) cells) after incubation with ConA. Addition of cells treated with melphalan alone (without ConA) to fresh cultures led to an increase in the allogeneic response.

PubMed Disclaimer

References

    1. Ben-Efraim S, Bocian RC, Mokyr MB, Dray S. Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytomas tumor growth. Cancer Immunol Immunother. 1983;15:101. - PMC - PubMed
    1. Ben-Efraim S, Komlos L, Notmann J, Hart J, Halbrecht I. In vitro selective effect of melphalan on human T-cell populations. Cancer Immunol Immunother. 1985;19:53. - PMC - PubMed
    1. Bocian RC, Ben-Efraim S, Dray S, Mokyr MB. Melphalan-mediated potentiation of antitumor responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor. Cancer Immunol Immunother. 1984;18:41. - PMC - PubMed
    1. Diamanstein T, Klos M, Hahn H, Kaufman SHE. Direct in vitro evidence for different susceptibilities to 4-hydroxyperoxycyclophosphamide of antigen-primed T cells regulating humoral and cell-mediated immune response to sheep erythrocytes: a possible explanation for the inverse action of cyclophosphamide on humoral and cell-mediated immune resonse. J Immunol. 1981;126:1717. - PubMed
    1. Dray S, Mokyr MB (1985) Immunomodulation by cyclophosphamide and its effect on eradication of established tumors. In: Fudenberg H, Ambrogy F (eds) Frontiers in Immunomodulation. Plenum Press New York, (in press)

Publication types

LinkOut - more resources